Drug Shortage Report for TEVA-TRIACOMB

Last updated on 2023-07-14 History
Report ID 153153
Drug Identification Number 00550507
Brand name TEVA-TRIACOMB
Common or Proper name TRIACOMB CREAM
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) GRAMICIDIN NEOMYCIN NYSTATIN TRIAMCINOLONE ACETONIDE
Strength(s) 0.25MG 2.5MG 100000UNIT 1MG
Dosage form(s) CREAM
Route of administration TOPICAL TOPICAL
Packaging size 30G
ATC code D07CB
ATC description CORTICOSTEROIDS, COMB WITH ANTIBIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-01-19
Estimated end date 2023-07-30
Actual end date 2023-07-13
Shortage status Resolved
Updated date 2023-07-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-01-20 English Compare
v2 2022-01-20 French Compare
v3 2022-03-03 English Compare
v4 2022-03-03 French Compare
v5 2022-03-17 English Compare
v6 2022-03-17 French Compare
v7 2022-04-21 English Compare
v8 2022-04-21 French Compare
v9 2022-06-03 English Compare
v10 2022-06-03 French Compare
v11 2022-06-16 English Compare
v12 2022-06-16 French Compare
v13 2022-06-30 English Compare
v14 2022-06-30 French Compare
v15 2022-08-18 English Compare
v16 2022-08-18 French Compare
v17 2022-12-01 English Compare
v18 2022-12-01 French Compare
v19 2022-12-01 English Compare
v20 2022-12-01 French Compare

Showing 1 to 20 of 31